Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

Kim YJ, Lee HS, Im JP, Min BH, Kim HD, Jeong JB, Yoon JH, Kim CY, Kim MS, Kim JY, Jung JH, Kim LH, Park BL, Shin HD.

Exp Mol Med. 2003 Jun 30;35(3):196-202.

PMID:
12858019
2.

-509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.

Qi P, Chen YM, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y, Gao CF.

Cancer Immunol Immunother. 2009 Sep;58(9):1433-40. doi: 10.1007/s00262-009-0660-4. Epub 2009 Jan 25.

PMID:
19169878
3.

Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.

Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K, Hamasaki K, Yatsuhashi H, Ishibashi H, Eguchi K.

J Hepatol. 2005 Apr;42(4):505-10. Epub 2004 Dec 10.

PMID:
15763337
4.

Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.

Radwan MI, Pasha HF, Mohamed RH, Hussien HI, El-Khshab MN.

Cytokine. 2012 Oct;60(1):271-6. doi: 10.1016/j.cyto.2012.05.010. Epub 2012 Jun 6.

PMID:
22682513
5.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025. Epub 2011 Oct 12.

PMID:
22019522
6.

Effect of IL-12B, IL-2, TGF-β1, and IL-4 polymorphism and expression on hepatitis B progression.

Saxena R, Chawla YK, Verma I, Kaur J.

J Interferon Cytokine Res. 2014 Feb;34(2):117-28. doi: 10.1089/jir.2013.0043. Epub 2013 Oct 26.

PMID:
24161121
7.

Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients.

Xin Z, Zhang W, Xu A, Zhang L, Yan T, Li Z, Wu X, Zhu X, Ma J, Li K, Li H, Liu Y.

Mol Carcinog. 2012 Oct;51 Suppl 1:E123-31. doi: 10.1002/mc.21876. Epub 2012 Jan 30.

PMID:
22290546
8.

IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

Li N, Zhu Q, Li Z, Han Q, Zhang G, Chen J, Lv Y, Xing F, Chen Y, Zeng X, Liu Z.

Mol Carcinog. 2014 Jun;53(6):447-57. doi: 10.1002/mc.21992. Epub 2012 Dec 31.

PMID:
23280722
9.

Polymorphisms in TGF-beta1 gene and the risk of lung cancer.

Kang HG, Chae MH, Park JM, Kim EJ, Park JH, Kam S, Cha SI, Kim CH, Park RW, Park SH, Kim YL, Kim IS, Jung TH, Park JY.

Lung Cancer. 2006 Apr;52(1):1-7. Epub 2006 Feb 24.

PMID:
16499994
10.
11.

Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.

Wei YS, Zhu YH, Du B, Yang ZH, Liang WB, Lv ML, Kuang XH, Tai SH, Zhao Y, Zhang L.

Clin Chim Acta. 2007 May 1;380(1-2):165-9. Epub 2007 Feb 15.

PMID:
17368597
12.

The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.

Eliopoulos DG, Mavroudi I, Pontikoglou C, Ximeri M, Stavroulaki E, Pyrovolaki K, Velegraki M, Spanoudakis M, Goulielmos G, Papadaki HA.

Eur J Haematol. 2009 Dec 1;83(6):535-40. doi: 10.1111/j.1600-0609.2009.01319.x. Epub 2009 Jul 14.

PMID:
19614955
13.

Putative association of transforming growth factor-alpha polymorphisms with clearance of hepatitis B virus and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.

Kim YJ, Kim HY, Kim JS, Lee JH, Yoon JH, Kim CY, Park BL, Cheong HS, Bae JS, Kim S, Shin HD, Lee HS.

J Viral Hepat. 2010 Jul;17(7):518-26. doi: 10.1111/j.1365-2893.2009.01205.x. Epub 2009 Sep 25.

PMID:
19780938
14.

[Effect of polymorphism of transforming growth factor beta1 gene on HBV-induced liver cirrhosis].

Yang ZX, Wang H, Gao CF, Xu LL, Zhao WJ.

Zhonghua Yi Xue Za Zhi. 2005 Apr 20;85(15):1021-6. Chinese.

PMID:
16029542
16.

TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.

Kim JH, Yu SJ, Park BL, Cheong HS, Pasaje CF, Bae JS, Lee HS, Shin HD, Kim YJ.

Dig Dis. 2011;29(3):278-83. doi: 10.1159/000327559. Epub 2011 Aug 9.

PMID:
21829018
17.

Association between transforming growth factor-β1 -509 C>T variants and hepatocellular carcinoma susceptibility: a meta-analysis.

Toshikuni N, Matsue Y, Minato T, Hayashi N, Tsutsumi M.

Neoplasma. 2016;63(6):961-966.

PMID:
27596296
18.

TGF-β1 polymorphism 509 C>T is associated with an increased risk for hepatocellular carcinoma in HCV-infected patients.

Ma J, Liu YC, Fang Y, Cao Y, Liu ZL.

Genet Mol Res. 2015 May 4;14(2):4461-8. doi: 10.4238/2015.May.4.3.

19.

Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy.

Beránek M, Kanková K, Benes P, Izakovicová-Hollá L, Znojil V, Hájek D, Vlková E, Vácha J.

Am J Med Genet. 2002 May 15;109(4):278-83.

PMID:
11992481
20.

[Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].

Park JS, Cheong JY, Kang JK, Cho JH, Yu S, Shin HD, Park BL, Cho SW.

Korean J Gastroenterol. 2007 Nov;50(5):313-8. Korean.

Supplemental Content

Support Center